Selexipag

Selexipag (brand name Uptravi) is a drug developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.

单词	Selexipag
释义	Selexipag 英语百科 Selexipag Selexipag (brand name Uptravi) is a drug developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.
随便看	bulwark mooring pipe bulwark netting bulwark plate bulwark plating bulwark port bulwark rail bulwarks bulwark stanchion bulwark stay bulwark strake Bulwell Bulweria bulwerii Bulwer Lytton bulwerlytton Bulwer Bulwer, Sir Henry Bulwick Bulworth Bulyea Bulygen Bulygen number bulyiement Bulz Bulzi Bulē